-----
I am constantly updating this post as I come across additional relevant material.
-----
Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons, 2024
ascopubs.org/doi/10.1200/ED....
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer, 2023
ncbi.nlm.nih.gov/pmc/articl...
Immunotherapy for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives, 2023
ncbi.nlm.nih.gov/pmc/articl...
Neuroendocrine Tumor Lu-177-Dotatate Therapy, 2023
ncbi.nlm.nih.gov/books/NBK5...
Neuroendocrine and Aggressive-Variant Prostate Cancer, 2020
ncbi.nlm.nih.gov/pmc/articl...
Special Note:
BXCL701 Gains Fast Track Designation for mCRPC Treatment!
targetedonc.com/view/bxcl70...
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
clinicaltrials.ucbraid.org/...
AOH1996 for the Treatment of Refractory Solid Tumors
cityofhope.org/targeted-che...
clinicaltrials.gov/study/NC...
------
The diagram is from - Current and emerging therapies for neuroendocrine prostate cancer, 2022. I got this paper using the Elsevier patient access program.